Thomas K Equels Aim Immuno Tech Inc. (AIM) insider trading activity

AIM Quotes by TradingView

Thomas K Equels is CEO & President of AIM ImmunoTech Inc.. Currently has a direct ownership of 778,184 shares of AIM, which is worth approximately $350,182. The most recent transaction as insider was on May 06, 2024, when has been sold 61,729 shares (Common Stock) at a price of $0.4 per share, resulting in proceeds of $24,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 778K
8.62% 3M change
43.05% 12M change
Total Value Held $350,182

Thomas K Equels Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 06 2024
BUY
Open market or private purchase
$24,691 $0.4 p/Share
61,729 Added 7.35%
778,184 Common Stock
Mar 15 2024
BUY
Open market or private purchase
$25,000 $0.33 p/Share
75,758 Added 9.56%
716,455 Common Stock
Nov 27 2023
BUY
Open market or private purchase
$14,898 $0.44 p/Share
33,861 Added 5.02%
640,697 Common Stock
Sep 29 2023
BUY
Open market or private purchase
$9,977 $0.44 p/Share
22,676 Added 3.6%
606,836 Common Stock
Aug 25 2023
BUY
Open market or private purchase
$5,508 $0.67 p/Share
8,222 Added 1.39%
584,160 Common Stock
Aug 24 2023
BUY
Open market or private purchase
$10,045 $0.67 p/Share
14,993 Added 2.54%
575,938 Common Stock
Jul 17 2023
BUY
Open market or private purchase
$10,000 $0.59 p/Share
16,950 Added 2.93%
560,945 Common Stock
Jan 03 2023
BUY
Open market or private purchase
$50,000 $0.31 p/Share
161,291 Added 22.87%
543,995 Common Stock
Jul 18 2022
BUY
Grant, award, or other acquisition
$25,000 $0.76 p/Share
32,895 Added 7.92%
382,704 Common Stock
Apr 25 2022
BUY
Grant, award, or other acquisition
$50,000 $1.02 p/Share
49,020 Added 12.29%
349,809 Common Stock
Dec 13 2021
BUY
Grant, award, or other acquisition
$25,000 $1.16 p/Share
21,552 Added 6.69%
300,789 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
$15,000 $1.27 p/Share
11,811 Added 4.06%
279,237 Common Stock
Nov 24 2021
BUY
Grant, award, or other acquisition
$14,999 $1.29 p/Share
11,627 Added 4.17%
267,426 Common Stock
Nov 23 2021
BUY
Grant, award, or other acquisition
$15,000 $1.34 p/Share
11,194 Added 4.19%
255,799 Common Stock
Nov 19 2021
BUY
Grant, award, or other acquisition
$15,000 $1.47 p/Share
10,204 Added 4.0%
244,605 Common Stock
Nov 17 2021
BUY
Grant, award, or other acquisition
$14,999 $1.64 p/Share
9,146 Added 3.76%
234,401 Common Stock
Jul 16 2021
BUY
Open market or private purchase
$30,000 $1.92 p/Share
15,625 Added 6.49%
225,255 Common Stock
Feb 24 2021
BUY
Open market or private purchase
$25,000 $2.26 p/Share
11,062 Added 5.01%
209,630 Common Stock
Dec 17 2020
BUY
Open market or private purchase
$25,000 $1.72 p/Share
14,535 Added 6.82%
198,568 Common Stock
TKE

Thomas K Equels

CEO & President
Ocala, FL

Track Institutional and Insider Activities on AIM

Follow AIM ImmunoTech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIM shares.

Notify only if

Insider Trading

Get notified when an Aim Immuno Tech Inc. insider buys or sells AIM shares.

Notify only if

News

Receive news related to AIM ImmunoTech Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AIM